eLife

Latest preprint reviews

1. We couldn't get details of this article at this time:
   10.1101/2023.11.29.569214

2. We couldn't get details of this article at this time:
   10.1101/2023.05.11.540393

3. We couldn't get details of this article at this time:
   10.1101/2023.10.24.563760

4. We couldn't get details of this article at this time:
   10.1101/2021.12.08.471801

5. We couldn't get details of this article at this time:
   10.1101/2024.01.03.574004

6. Large pan-cancer cell screen coupled to (phospho-)proteomics underscores high-dose vitamin C as a potent anti-cancer agent

   This article has 18 authors:

   1. Andrea Vallés-Martí
   2. Franziska Böttger
   3. Elysia Yau
   4. Khadija Tejjani
   5. Loes Meijs
   6. Sugandhi Sharma
   7. Madiha Mumtaz
   8. Tessa Y. S. Le Large
   9. Ayse Erozenci
   10. Daniëlle Dekker
   11. Tim Schelfhorst
   12. Jan Paul Medema
   13. Irene V Bijnsdorp
   14. Jaco C Knol
   15. Sander R Piersma
   16. Thang V. Pham
   17. Elisa Giovannetti
   18. Connie R Jiménez

   This article has been curated by 1 group:

   • Curated by eLife

     eLife assessment

     This useful study utilizes proteomics analysis across a large panel of 51 cancer cell lines to elucidate mechanisms underlying the sensitivity of cancer cells to high-dose vitamin C (Ascorbate). While the associations between specific molecular pathways and sensitivity to ascorbate are interesting, a major limitation is that the study is largely descriptive and incomplete, lacking evidence on the molecular underpinnings of cancer cells' sensitivity to high-dose vitamin C.

   Reviewed by eLife

7. We couldn't get details of this article at this time:
   10.1101/2022.02.15.480392

8. We couldn't get details of this article at this time:
   10.1101/2021.10.20.464767

9. We couldn't get details of this article at this time:
   10.1101/2023.10.12.562061

10. We couldn't get details of this article at this time:
    10.1101/2023.10.30.564869